MRP4 knockdown enhances migration, suppresses apoptosis, and produces aggregated morphology in human retinal vascular endothelial cells

Biochemical and Biophysical Research Communications

Volumn 400, Issue 4, 2010, Pages 593-598

  Tagami, Mizuki ^a   Kusuhara, Sentaro ^a   Imai, Hisanori ^a   Uemura, Akiyoshi ^a   Honda, Shigeru ^a   Tsukahara, Yasutomo ^a   Negi, Akira ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; ATP binding cassette transporter; Multidrug resistance protein 4; Retinal endothelial cell; RNA interference

Indexed keywords

MATRIGEL; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 4; RNA; SMALL INTERFERING RNA; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL AGGREGATION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; STARVATION; VASCULAR ENDOTHELIUM;

APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GENE KNOCKDOWN TECHNIQUES; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; RETINA; RETINAL NEOVASCULARIZATION; RETINAL VESSELS;

RODENTIA;

EID: 77957283600     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.08.109     Document Type: Article

References (27)

1. Rees D.C., Johnson E., Lewinson O. ABC transporters: the power to change. Nat. Rev. Mol. Cell Biol. 2009, 10:218-227.
2. Borst P., Evers R., Kool M., Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst. 2000, 92:1295-1302.
3. Tian Q., Zhang J., Tan T.M., Chan E., Duan W., Chan S.Y., Boelsterli U.A., Ho P.C., Yang H., Bian J.S., Huang M., Zhu Y.Z., Xiong W., Li X., Zhou S. Human multidrug resistance associated protein 4 confers resistance to camptothecins. Pharm. Res. 2005, 22:1837-1853.
4. Borst P., de Wolf C., van de Wetering K. Multidrug resistance-associated proteins 3, 4, and 5. Pflugers Arch. 2007, 453:661-673.
5. Tachikawa M., Toki H., Tomi M., Hosoya K. Gene expression profiles of ATP-binding cassette transporter A and C subfamilies in mouse retinal vascular endothelial cells. Microvasc. Res. 2008, 75:68-72.
6. Tagami M., Kusuhara S., Honda S., Tsukahara Y., Negi A. Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy. Brain Res. 2009, 1283:186-193.
7. Leggas M., Adachi M., Scheffer G.L., Sun D., Wielinga P., Du G., Mercer K.E., Zhuang Y., Panetta J.C., Johnston B., Scheper R.J., Stewart C.F., Schuetz J.D. Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol. Cell. Biol. 2004, 24:7612-7621.
8. Belinsky M.G., Guo P., Lee K., Zhou F., Kotova E., Grinberg A., Westphal H., Shchaveleva I., Klein-Szanto A., Gallo J.M., Kruh G.D. Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damage. Cancer Res. 2007, 67:262-268.
9. Barakat S., Turcotte S., Demeule M., Lachambre M.P., Regina A., Baggetto L.G., Beliveau R. Regulation of brain endothelial cells migration and angiogenesis by P-glycoprotein/caveolin-1 interaction. Biochem. Biophys. Res. Commun. 2008, 372:440-446.
10. Noda K., Zhang J., Fukuhara S., Kunimoto S., Yoshimura M., Mochizuki N. Vascular endothelial-cadherin stabilizes at cell-cell junctions by anchoring to circumferential actin bundles through alpha- and beta-catenins in cyclic AMP-Epac-Rap1 signal-activated endothelial cells. Mol. Biol. Cell 2010, 21:584-596.
11. Maher J.M., Dieter M.Z., Aleksunes L.M., Slitt A.L., Guo G., Tanaka Y., Scheffer G.L., Chan J.Y., Manautou J.E., Chen Y., Dalton T.P., Yamamoto M., Klaassen C.D. Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology 2007, 46:1597-1610.
12. Cai C., Omwancha J., Hsieh C.L., Shemshedini L. Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells. Prostate Cancer Prostatic Dis. 2007, 10:39-45.
13. Gradilone A., Pulcinelli F.M., Lotti L.V., Martino S., Mattiello T., Frati L., Agliano A.M., Gazzaniga P. Celecoxib induces MRP-4 in lung cancer cells: therapeutic implications. J. Clin. Oncol. 2007, 25:4318-4320.
14. author reply 4320.
15. Sassi Y., Lipskaia L., Vandecasteele G., Nikolaev V.O., Hatem S.N., Cohen Aubart F., Russel F.G., Mougenot N., Vrignaud C., Lechat P., Lompre A.M., Hulot J.S. Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation. J. Clin. Invest. 2008, 118:2747-2757.
16. van de Ven R., Scheffer G.L., Reurs A.W., Lindenberg J.J., Oerlemans R., Jansen G., Gillet J.P., Glasgow J.N., Pereboev A., Curiel D.T., Scheper R.J., de Gruijl T.D. A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration. Blood 2008, 112:2353-2359.
17. Russel F.G., Koenderink J.B., Masereeuw R. Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules. Trends Pharmacol. Sci. 2008, 29:200-207.
18. Lin Z.P., Zhu Y.L., Johnson D.R., Rice K.P., Nottoli T., Hains B.C., McGrath J., Waxman S.G., Sartorelli A.C. Disruption of cAMP and prostaglandin E2 transport by multidrug resistance protein 4 deficiency alters cAMP-mediated signaling and nociceptive response. Mol. Pharmacol. 2008, 73:243-251.
19. Torella D., Gasparri C., Ellison G.M., Curcio A., Leone A., Vicinanza C., Galuppo V., Mendicino I., Sacco W., Aquila I., Surace F.C., Luposella M., Stillo G., Agosti V., Cosentino C., Avvedimento E.V., Indolfi C. Differential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP/PKA-activated p85alphaPI3K. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H2015-2025.
20. Milan J., Charalambous C., Elhag R., Chen T.C., Li W., Guan S., Hofman F.M., Zidovetzki R. Multiple signaling pathways are involved in endothelin-1-induced brain endothelial cell migration. Am. J. Physiol. Cell Physiol. 2006, 291:C155-C164.
21. Hippenstiel S., Schmeck B., N'Guessan P.D., Seybold J., Krull M., Preissner K., Eichel-Streiber C.V., Suttorp N. Rho protein inactivation induced apoptosis of cultured human endothelial cells. Am. J. Physiol. Lung. Cell. Mol. Physiol. 2002, 283:L830-L838.
22. Yanni S.E., Barnett J.M., Clark M.L., Penn J.S. The role of PGE2 receptor EP4 in pathologic ocular angiogenesis. Invest. Ophthalmol. Vis. Sci. 2009, 50:5479-5486.
23. Rao R., Redha R., Macias-Perez I., Su Y., Hao C., Zent R., Breyer M.D., Pozzi A. Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo. J. Biol. Chem. 2007, 282:16959-16968.
24. Arnaoutova I., George J., Kleinman H.K., Benton G. The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis 2009, 12:267-274.
25. Cullere X., Shaw S.K., Andersson L., Hirahashi J., Luscinskas F.W., Mayadas T.N. Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase. Blood 2005, 105:1950-1955.
26. Fukuhara S., Sakurai A., Sano H., Yamagishi A., Somekawa S., Takakura N., Saito Y., Kangawa K., Mochizuki N. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol. Cell. Biol. 2005, 25:136-146.
27. Kooistra M.R., Corada M., Dejana E., Bos J.L. Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett. 2005, 579:4966-4972.